Scrip
Executive Briefing – Brazil emerges as a saviour for pharma
30 September 2009
Sita Shah
Please Login to read the full article.
30 September 2009
Sita Shah
sita.shah@informa.com
Big pharma companies need to expand in fast-growing, emerging markets to offset declining returns on investment in developed countries. As the second largest emerging pharmaceutical market after China, and among the world's top 10 pharmaceutical markets overall, Brazil offers huge potential...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Interview: Lupin set for Latin American buy as it expands internationally
- Interview: Indian family-owned firms becoming more open to sell-off option
- Pharma sales to reach $1.1 trillion in 2014, says IMS Health
- 2009 results preview: big pharma grapples to varying degrees of success with generic erosion
COMMENT
Other Informa Comment
FEATURES
- Face to Face with Sandoz's "growth guy" Jeff George
- Roche's Asian partnering head looks to tap regional innovation
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
